125 related articles for article (PubMed ID: 26195837)
21. Transcortical selective amygdalohippocampectomy in temporal lobe epilepsy.
Olivier A
Can J Neurol Sci; 2000 May; 27 Suppl 1():S68-76; discussion S92-6. PubMed ID: 10830331
[TBL] [Abstract][Full Text] [Related]
22. Visual field defects in selective amygdalohippocampectomy for hippocampal sclerosis: the fate of Meyer's loop during the transsylvian approach to the temporal horn.
Yeni SN; Tanriover N; Uyanik O; Ulu MO; Ozkara C; Karaağaç N; Ozyurt E; Uzan M
Neurosurgery; 2008 Sep; 63(3):507-13; discussion 513-5. PubMed ID: 18812962
[TBL] [Abstract][Full Text] [Related]
23. Selective Amygdalohippocampectomy.
Hoyt AT; Smith KA
Neurosurg Clin N Am; 2016 Jan; 27(1):1-17. PubMed ID: 26615103
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm.
Liu JK; Tenner MS; Gottfried ON; Stevens EA; Rosenow JM; Madan N; MacDonald JD; Kestle JR; Couldwell WT
J Neurosurg; 2004 Mar; 100(3):414-21. PubMed ID: 15035276
[TBL] [Abstract][Full Text] [Related]
25. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
[TBL] [Abstract][Full Text] [Related]
26. Potential contribution of matrix metalloproteinase-9 (mmp-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats.
Wang Z; Fang Q; Dang BQ; Shen XM; Shu Z; Zuo G; He WC; Chen G
Ann Clin Lab Sci; 2012; 42(1):14-20. PubMed ID: 22371905
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic stability after intraarterial injection of verapamil for cerebral vasospasm.
Flexman AM; Ryerson CJ; Talke PO
Anesth Analg; 2012 Jun; 114(6):1292-6. PubMed ID: 22451596
[TBL] [Abstract][Full Text] [Related]
28. Effect of selective inhibitor of thromboxane A2 synthetase on experimental cerebral vasospasm.
Fukumori T; Tani E; Maeda Y; Sukenaga A
Stroke; 1984; 15(2):306-11. PubMed ID: 6538355
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C and cerebral vasospasm.
Laher I; Zhang JH
J Cereb Blood Flow Metab; 2001 Aug; 21(8):887-906. PubMed ID: 11487724
[TBL] [Abstract][Full Text] [Related]
30. Continuous elevation of intracellular Ca2+ is essential for the development of cerebral vasospasm.
Tani E; Matsumoto T
Curr Vasc Pharmacol; 2004 Jan; 2(1):13-21. PubMed ID: 15320829
[TBL] [Abstract][Full Text] [Related]
31. Intra-arterial injection of verapamil in treatment of cerebral vasospasm in a patient with acute subarachnoid hemorrhage from an aneurysm: case report.
Mikeladze KG; Éliava ShSh; Shekhtman OD; Lubnin AIu; Tabasaranskiĭ TF; Iakovlev SB
Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(4):57-60; discussion 60. PubMed ID: 24364247
[TBL] [Abstract][Full Text] [Related]
32. [Possible role of microthrombus in the pathogenesis of cerebral vasospasm (author's transl)].
Suzuki S; Sobata E; Ando A; Iwabuchi T
No Shinkei Geka; 1982 Jan; 10(1):45-52. PubMed ID: 7043295
[TBL] [Abstract][Full Text] [Related]
33. Selective amygdalohippocampectomy via the transsylvian approach.
Adada B
Neurosurg Focus; 2008 Sep; 25(3):E5. PubMed ID: 18759629
[TBL] [Abstract][Full Text] [Related]
34. Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function.
Vatter H; Konczalla J; Weidauer S; Preibisch C; Zimmermann M; Raabe A; Seifert V
J Neurosurg; 2007 Jul; 107(1):121-7. PubMed ID: 17639881
[TBL] [Abstract][Full Text] [Related]
35. Prevention of cerebral ischemic symptoms in cerebral vasospasm with trapidil, an antagonist and selective synthesis inhibitor of thromboxane A2.
Suzuki S; Sobata E; Iwabuchi T
Neurosurgery; 1981 Dec; 9(6):679-85. PubMed ID: 7322333
[TBL] [Abstract][Full Text] [Related]
36. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
[TBL] [Abstract][Full Text] [Related]
37. Current management and treatment of cerebral vasospasm complicating SAH.
Kühn AL; Balami JS; Grunwald IQ
CNS Neurol Disord Drug Targets; 2013 Mar; 12(2):233-41. PubMed ID: 23394535
[TBL] [Abstract][Full Text] [Related]
38. Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm.
Yokota M; Tani E; Maeda Y; Kokubu K
Stroke; 1987; 18(2):512-8. PubMed ID: 3564111
[TBL] [Abstract][Full Text] [Related]
39. Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice.
Wakade C; King MD; Laird MD; Alleyne CH; Dhandapani KM
Antioxid Redox Signal; 2009 Jan; 11(1):35-45. PubMed ID: 18752423
[TBL] [Abstract][Full Text] [Related]
40. Paradoxical aggravation of vasospasm with papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report.
Clyde BL; Firlik AD; Kaufmann AM; Spearman MP; Yonas H
J Neurosurg; 1996 Apr; 84(4):690-5. PubMed ID: 8613866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
